Platinum-Based Cancer Drug Market Set to Reach USD 1.76 Billion by 2032 | Key Growth Insights and Leading Players
According to a new report from Intel Market Research, Global platinum-based cancer drug market was valued at USD 1.44 billion in 2025 and is projected to reach USD 1.76 billion by 2032, exhibiting a CAGR of 2.9% during the forecast period. Get FREE Sample of this Report at https://www.intelmarketresearch.com/download-free-sample/16359/platinum-based-cancer-drug-market Fueled by advances in oncology research … Read more